James Tonra, PhD

James Tonra, PhD has had an extensive career in the pharmaceutical industry. James is currently serving as the President and Chief Scientific Officer at Seed Therapeutics since April 2022. Prior to this, they held the position of Chief Scientific Officer at Evrys Bio from March 2021 to April 2022, and at BeyondSpring from April 2018 to March 2021.

Before joining Evrys Bio, James Tonra worked at Kadmon Holdings, LLC as a Senior Vice President from 2011 to 2017. James also served as an Associate Vice President at ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company from 2003 to 2011.

James'sprofessional journey began at Millennium Pharmaceuticals, Inc. as a Scientist II from 1999 to 2003. Prior to that, they worked as an Associate Scientist at Millennium Biotherapeutics from 1998 to 1999. James'scareer in the pharmaceutical industry commenced at Regeneron Pharmaceuticals, Inc. where they served as a Postdoctoral Fellow from 1996 to 1998.

James Tonra, PhD attended Stony Brook University for an unspecified period of time. However, no specific details about the degree or field of study pursued at the institution are provided.